(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

APOLIPOPROTEÍNA E2 E TRATAMENTO DE DOENÇA DE ALZHEIMER

IndeferidaInvention PatentPCT · US1996017629

Application data

Number

PI9611329

Type

Invention Patent

Filing

10/31/1996

Publication

12/28/1999

PCT

US1996017629

Progress at the INPI

Under appeal
  1. Filing10/31/96
  2. Publication12/28/99
  3. Examination
  4. Refused11/25/03
  5. Grant
  6. In force

The application was refused by the INPI on 11/25/2003. The invention was never patented.

Talk to a specialist

Latest action published by the INPI: 11/25/2003. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Kos Pharmaceuticals, Inc

US

T. U. (pessoa física)

US

Inventors

S. A. (pessoa física)

US

V. Z. (pessoa física)

US

Technical data

Priority claims

US

551722 · 11/01/1995

Abstract

Patente de Invenção: "APOLIPOPROTEÍNA E2 E TRATAMENTO DE DOENÇA DE ALZHEIMER" . Apolipoproteína E2 (apoE2) recombinante que se liga ao peptídeo amilóide A .

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Indeferimento

#9.2

Indeferido de acordo com o art. 8º, em vista do(s) art.(s). 11 da LPI.

11/25/2003

RPI 1716

Conhecimento de parecer técnico

#7.1

06/03/2003

RPI 1691

Notificação de entrada na fase nacional - PCT

#1.3

12/28/1999

RPI 1512

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.